Ambiq Micro
AMBQ
61.98
-1.26
-1.99%
Ambiq Micro
US · AMBQ
#2941 by market cap
Listed 2025
61.98
-1.26
-1.99%
Live - 5344 symbols - heartbeat 518s ago
· 2026-10-08 07:29
Pre-market
60.50
-2.39%
After-hours
61.98
0.00%
Overnight
61.59
-0.63%
- Market cap
- 1.50B
- P/E (TTM)i
- -40.48
- P/Bi
- 3.70
- EPSi
- -1.99
- Div yieldi
- 0.00%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on AMBQ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 38.42, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year -4.67% YoY
Margins
- Gross margin
- 44.26%
- Operating margin
- -54.53%
- Net margin
- -50.28%
Key ratios & quality
- Altman Z-Scorei
- 38.42
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 50.97M | 91.01M | 65.54M | 76.07M | 72.51M |
| Gross profit | 21.57M | 30.77M | 19.44M | 24.29M | 32.10M |
| Selling & admin expenses | 14.00M | 19.13M | 26.74M | 27.74M | 33.15M |
| Research & development | 27.79M | 36.11M | 44.02M | 37.17M | 38.49M |
| Operating profit | -20.22M | -24.47M | -51.32M | -40.61M | -39.54M |
| Pretax profit | -25.20M | -25.32M | -50.30M | -39.63M | -36.42M |
| Tax | 25.00K | 25.00K | 30.00K | 28.00K | 40.00K |
| Net profit | -25.22M | -25.34M | -50.33M | -39.66M | -36.46M |
| Basic EPS | -2 | 0 | -5 | -2 | -5 |
| Diluted EPS | -1.85 | -0.10 | -5.00 | -2.40 | -4.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 15.73M | 17.87M | 18.17M | 20.74M | 25.06M | 33.90M |
| Gross profit | 8.39M | 7.17M | 7.68M | 8.86M | 10.89M | 15.27M |
| Selling & admin expenses | 8.44M | 7.07M | 8.83M | 8.81M | 9.75M | 9.86M |
| Research & development | 8.69M | 8.90M | 8.89M | 12.01M | 12.83M | 14.14M |
| Operating profit | -8.74M | -8.80M | -10.04M | -11.96M | -11.69M | -8.73M |
| Pretax profit | -8.28M | -8.48M | -9.00M | -10.66M | -10.17M | -7.11M |
| Tax | 4.00K | 14.00K | 3.00K | 19.00K | 3.00K | 1.00K |
| Net profit | -8.28M | -8.50M | -9.00M | -10.68M | -10.17M | -7.12M |
| Basic EPS | 0 | 0 | -1 | -1 | -1 | 0 |
| Diluted EPS | -0.47 | -0.48 | -0.72 | -0.58 | -0.50 | -0.32 |
Balance sheet
| Line item | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 94.79M | 98.84M | 63.86M | 88.96M | 167.92M |
| Cash & ST investments | 65.05M | 25.92M | 27.32M | 60.98M | 140.28M |
| Inventory | 7.44M | 33.68M | 21.48M | 15.01M | 16.94M |
| Total assets | 99.68M | 105.13M | 72.43M | 104.28M | 184.68M |
| Total current liabilities | 6.08M | 14.80M | 12.92M | 11.77M | 19.18M |
| Short-term debt | -- | -- | 804.00K | 633.00K | 400.00K |
| Long-term debt | -- | -- | -- | -- | -- |
| Total liabilities | 7,381,000.00 | 16,120,000.00 | 13,299,000.00 | 18,530,000.00 | 22,221,000.00 |
| Total equity | 92.30M | 89.01M | 59.13M | 85.75M | 162.46M |
| Retained earnings | -132.76M | -158.10M | -277.87M | -320.25M | -356.71M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 83.27M | 74.89M | 173.02M | 167.92M | 241.66M | 416.63M |
| Cash & ST investments | 61.42M | 47.51M | 146.49M | 140.28M | 204.54M | 366.77M |
| Inventory | 15.29M | 15.76M | 16.13M | 16.94M | 23.46M | 29.37M |
| Total assets | 99.30M | 89.16M | 186.73M | 184.68M | 259.52M | 435.62M |
| Total current liabilities | 14.85M | 13.36M | 13.27M | 19.18M | 20.65M | 26.12M |
| Short-term debt | 579.00K | 402.00K | 402.00K | 400.00K | 982.00K | 1.03M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 20,862,000.00 | 18,324,000.00 | 16,940,000.00 | 22,221,000.00 | 24,362,000.00 | 30,950,000.00 |
| Total equity | 78.43M | 70.84M | 169.79M | 162.46M | 235.16M | 404.67M |
| Retained earnings | -328.53M | -337.03M | -346.03M | -356.71M | -366.88M | -374.00M |
Cash flow
| Line item | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -34.64M | -52.88M | -26.96M | -21.43M | -19.69M |
| Depreciation & amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| Free cash flow | -39.23M | -57.50M | -29.98M | -25.16M | -27.13M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 102.67M |
| Ending cash balance | 65.05M | 25.92M | 27.32M | 60.98M | 140.28M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.41M | -11.96M | -5.03M | -4.11M | -11.17M | -9.51M |
| Depreciation & amortization | 1.96M | 1.85M | 1.75M | 1.65M | 1.74M | 1.79M |
| Free cash flow | 290.00K | -13.98M | -6.74M | -6.71M | -15.19M | -11.39M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 99.84M | 2.83M | 76.83M | 168.64M |
| Ending cash balance | 61.42M | 47.51M | 146.49M | 140.28M | 204.54M | 366.77M |
Returns & efficiency
| Line item | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- |
| ROA %i | -25.30 | -24.75 | -72.17 | -47.97 | -25.24 |
| ROIC %i | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -39.66 | -26.88 | -78.31 | -53.39 | -54.53 |
| FCF / sales %i | -- | -- | -- | -- | -- |
| Current ratioi | 15.59 | 6.68 | 4.94 | 7.56 | 8.76 |
| Quick ratioi | 12.51 | 3.15 | 3.07 | 6.07 | 7.69 |
| Debt / assetsi | -- | -- | 1.41 | 0.93 | 0.37 |
| LT debt / equityi | -- | -- | -- | -- | 0.17 |
| Interest coveragei | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | 8.74 | -5.80 | -5.52 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -21.19 | -- | -- | -75.94 |
| ROA %i | -41.19 | -41.18 | -19.27 | -25.24 | -21.37 | -14.09 |
| ROIC %i | -- | -- | -21.09 | -- | -- | -71.91 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -52.44 | -51.20 | -52.63 | -54.53 | -51.92 | -43.34 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 5.61 | 5.60 | 13.04 | 8.76 | 11.70 | 15.95 |
| Quick ratioi | 4.41 | 4.14 | 11.57 | 7.69 | 10.44 | 14.71 |
| Debt / assetsi | 1.11 | 0.98 | 0.41 | 0.37 | 0.83 | 1.05 |
| LT debt / equityi | -- | -- | 0.22 | 0.17 | 0.49 | 0.88 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:29:13 · For reference only, not investment advice and not tailored to your situation.